VIALE, PIERLUIGI
 Distribuzione geografica
Continente #
NA - Nord America 21.767
AS - Asia 20.556
EU - Europa 19.793
SA - Sud America 1.613
AF - Africa 1.146
OC - Oceania 75
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 64.964
Nazione #
US - Stati Uniti d'America 21.499
SG - Singapore 6.919
CN - Cina 6.202
IT - Italia 5.429
GB - Regno Unito 4.266
VN - Vietnam 2.850
DE - Germania 2.622
SE - Svezia 1.885
HK - Hong Kong 1.579
NL - Olanda 1.417
BR - Brasile 1.169
IN - India 1.084
KR - Corea 943
RU - Federazione Russa 906
IE - Irlanda 609
FR - Francia 602
FI - Finlandia 378
UA - Ucraina 370
CI - Costa d'Avorio 365
ZA - Sudafrica 284
JP - Giappone 226
BG - Bulgaria 224
TG - Togo 212
EE - Estonia 201
AR - Argentina 196
CH - Svizzera 193
ID - Indonesia 176
AT - Austria 162
CA - Canada 152
JO - Giordania 146
ES - Italia 105
BE - Belgio 87
SC - Seychelles 83
MX - Messico 78
NG - Nigeria 78
PL - Polonia 74
AU - Australia 67
BD - Bangladesh 64
EC - Ecuador 63
CL - Cile 44
IR - Iran 41
LT - Lituania 37
RO - Romania 37
IQ - Iraq 34
PY - Paraguay 34
CO - Colombia 32
TR - Turchia 32
HR - Croazia 31
PE - Perù 31
MY - Malesia 30
PK - Pakistan 29
GR - Grecia 26
CD - Congo 24
MA - Marocco 24
PH - Filippine 23
LB - Libano 21
PT - Portogallo 19
CZ - Repubblica Ceca 17
TW - Taiwan 16
AE - Emirati Arabi Uniti 15
SA - Arabia Saudita 15
UZ - Uzbekistan 15
VE - Venezuela 15
DK - Danimarca 14
UY - Uruguay 14
KE - Kenya 13
SK - Slovacchia (Repubblica Slovacca) 13
EG - Egitto 12
HU - Ungheria 12
IL - Israele 12
KZ - Kazakistan 12
TH - Thailandia 12
TN - Tunisia 11
BO - Bolivia 10
AZ - Azerbaigian 9
AL - Albania 8
EU - Europa 8
HN - Honduras 7
LV - Lettonia 7
AM - Armenia 6
BH - Bahrain 6
DZ - Algeria 6
MK - Macedonia 6
RS - Serbia 6
BA - Bosnia-Erzegovina 5
CY - Cipro 5
DO - Repubblica Dominicana 5
NO - Norvegia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PA - Panama 5
BB - Barbados 4
CR - Costa Rica 4
ET - Etiopia 4
KG - Kirghizistan 4
KH - Cambogia 4
MD - Moldavia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
LU - Lussemburgo 3
ME - Montenegro 3
Totale 64.879
Città #
Singapore 4.675
Southend 3.850
Ashburn 2.801
Fairfield 2.266
Hefei 1.976
Hong Kong 1.559
Chandler 1.438
Santa Clara 1.153
Woodbridge 1.038
Bologna 971
Seattle 963
Seoul 926
Wilmington 923
Houston 884
Princeton 805
Frankfurt am Main 796
Cambridge 756
Ann Arbor 736
Beijing 666
Kerkrade 648
Dong Ket 612
Dublin 607
Ho Chi Minh City 588
Boardman 587
Milan 461
Hanoi 458
Abidjan 365
Dallas 360
Los Angeles 350
Rome 309
New York 297
Nanjing 280
Westminster 256
Helsinki 229
Padova 227
Berlin 219
Lomé 212
Sofia 206
Bengaluru 201
Tokyo 195
Redondo Beach 191
Buffalo 187
San Diego 170
Turin 157
Florence 154
Jinan 153
Amman 146
Saint Petersburg 146
Munich 131
Bern 129
Nuremberg 128
Chicago 126
São Paulo 126
Redmond 124
Shanghai 124
Jakarta 117
Bremen 112
Shenyang 112
Dearborn 97
Guangzhou 96
Changsha 95
Des Moines 91
Nanchang 91
Hebei 85
Lappeenranta 85
Jacksonville 84
Naples 83
Brescia 82
Vienna 81
Brussels 78
Redwood City 76
London 74
Amsterdam 72
Verona 71
Abeokuta 67
Tianjin 67
Olalla 66
Jiaxing 64
Zhengzhou 64
Falkenstein 63
Falls Church 63
Tongling 63
Genoa 60
Turku 60
Rio de Janeiro 57
Da Nang 53
Phoenix 53
Toronto 51
Mülheim 50
Council Bluffs 49
Hangzhou 48
Mumbai 48
Yubileyny 48
Parma 47
Norwalk 45
Bühl 44
San Francisco 43
Warsaw 43
Medford 42
Denver 41
Totale 42.122
Nome #
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 1.297
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa ? 882
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 543
[Prospective multicentre survey on clinical features and management approach to community-acquired pneumonia in emergency departments in Italy: focus on hospital admitted cases] 532
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 452
Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates 395
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 374
Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study. 353
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 292
Targeted Therapy of Severe Infections Caused by Staphylococcus aureus in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence 291
2017 WSES guidelines on colon and rectal cancer emergencies: Obstruction and perforation 291
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 288
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients 287
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 256
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 250
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation 242
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 235
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 234
Restriction Factors expression decreases in HIV-1 patients after cART 233
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 227
Infections in liver and lung transplant recipients: A national prospective cohort 221
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 211
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 210
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 210
Spinal tuberculosis: Proposed spinal infection multidisciplinary management project (SIMP) flow chart revision 209
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 207
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 204
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients. 204
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 204
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 204
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 204
Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: Sensitivity and specificity of current guidelines on bone mineral density management 203
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 201
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 196
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection 196
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 195
Chagas Disease in a Non-endemic Country: A Multidisciplinary Research, Bologna, Italy 190
A prospective survey of febrile events in hematological malignancies. 188
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 188
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 188
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 187
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach 184
Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study 182
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 182
Embracing tensions throughout crises: The case of an Italian university hospital during the COVID-19 pandemic 180
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 180
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 178
Pathological post-mortem findings in lungs infected with SARS-CoV-2 178
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 178
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 175
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. 174
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 174
PET con FDG nella dialisi peritoneale: le prospettive attuali e future 173
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies 173
Burkholderia cepacia infection in an infant affected by renal osteodystrophy 173
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 172
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 172
Schistosoma mansoni eggs in spleen and lungs, mimicking other diseases 172
Advances in the therapy of bacterial bloodstream infections 172
Bloodstream infections in patients with liver cirrhosis 170
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues 169
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells 169
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 166
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 165
Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. 165
Impact of preoperative infection on outcome after liver transplantation 165
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 164
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 164
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 163
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 163
Plasmodium falciparum malaria in migrants who transited Libya - Where did they contract malaria? 163
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals 163
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 162
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line. 162
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 161
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 161
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 161
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 160
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 160
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 160
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 158
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 158
Biopsy for suspected spondylodiscitis. 157
Impact of different antiretroviral strategies on total HIV-DNA level in virologically suppressed HIV-1 infected patients. 157
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study. 157
Meningitis caused by toscana virus is associated with strong antiviral response in the CNS and altered frequency of blood antigen-presenting cells 157
Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia 156
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 156
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 156
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 155
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 155
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 155
Classification performance for covid patient prognosis from automatic ai segmentation—a single-center study 154
A Case Report of Tolvaptan Therapy for ADPKD Patients with COVID-19. The Need for Appropriate Counselling for Temporary Drug Discontinuation 152
Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run 152
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 152
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study 152
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 152
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 152
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection. 151
Totale 21.876
Categoria #
all - tutte 194.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 194.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.435 0 0 0 0 0 357 200 303 506 358 283 1.428
2021/20227.359 582 286 420 581 662 386 245 584 324 746 1.342 1.201
2022/20237.575 758 995 392 993 566 543 257 512 1.331 273 550 405
2023/20243.613 245 420 231 349 311 569 283 280 185 308 208 224
2024/202513.898 558 1.681 1.128 1.097 1.841 738 1.081 544 350 988 1.128 2.764
2025/202618.386 3.118 3.536 2.957 2.709 3.082 2.984 0 0 0 0 0 0
Totale 66.553